SNGX
NASDAQ
$0.36
Soligenix Inc (SNGX)
Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States. The company is headquartered in Princeton, New Jersey.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $1.75 (+388.28%)
Market Cap
$3.91M
Beta (5Y)
1.15
Price Chart
Valuation
Market Cap$3.91M
Forward P/E12.32
P/S9.78
P/B1.70
Profitability
EBITDA-$11M
EPS-$1.58
Growth & Risk
EPS 5Y CAGR-33.62%
FCF 5Y CAGR-3.29%
Beta (5Y)1.15
Sharpe Ratio0.27